Provider P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates Read More Program effective Date: Aug 01, 2024
Provider P51-24 Inpatient Admission, Concurrent Review, and Discharge Submission Process Change for Commercial & Medicare Advantage Members Read More Program effective Date: Aug 01, 2024
Provider QP59-24 Commercial Pharmacy Benefit Exclusion for Select Medications Read More Program effective Date: Jul 24, 2024